• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Advent Technologies Reports Q2 2024 Results

    10/15/24 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ADN alert in real time by email

    Operational Highlights

    • Work continued on the Airbus-sponsored project to benchmark HT-PEM fuel cell MEAs in aviation for the second quarter. The project continued as planned without delays.
    • Met milestones with the U.S. Department of Defense on two previously awarded contracts for portable power systems.
    • Continued Technology Assessment Work for four of the largest 15 automotive manufacturers in the world.
    • Continued streamlining operations to significantly reduce OPEX and non-R&D development costs, primarily associated with overhead, facilities, and administrative personnel.

    LIVERMORE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, today announced consolidated financial results for the three months ended June 30, 2024. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP").

    Q2 2024 Financial Highlights

    (All comparisons are to Q2 2023, unless otherwise stated)

    • Revenue of $0.8 million and income from grants of $0.7 million, for a total of $1.5 million.
    • Operating expenses of $10.0 million, a year-over-year decrease of $1.2 million, primarily related to the streamlining of operations.
    • Net loss in Q2 of $(11.3) million or $(4.28) per share.
    • Unrestricted cash reserves were $0.7 million as of June 30, 2024, a decrease of $0.1 million from March 31, 2024.

    "We are on the road to becoming a much leaner and focused company with the goal to substantially reduce our cash burn. We aim to soon rely mostly on customer revenue and R&D grants for our operations rather than on fundraising. Towards that goal, we are focusing our activities on our Livermore and Patras offices that are leading the US Army, Airbus, and R&D product development efforts. Technology-wise, we have made great progress with the Advent MEA and expect to announce strong performance improvements to the market by year-end. I am thankful to our employees in the USA and Greece for performing excellent work during these hard financial times and meeting all customer milestones and requirements," said Dr. Vasilis Gregoriou, Chairman and CEO of Advent Technologies.

    Business Updates

    Airbus: The second quarter milestones were completed successfully, and the cooperation between the two companies continues to be strong. Aviation has by far the most challenging requirements compared to any other market. Advent believes that the benchmark performance achieved through this project will also be instrumental in achieving the performance requirements of other markets, especially stationary power, marine, and automotive.

    The project aims to accelerate the development of Advent's MEA and benchmark the Ion Pair MEA against aviation requirements and current/expected technological limits. HT-PEM MEAs operating at temperatures higher than 180°C (360°F) aim to solve one of the largest challenges in aviation fuel cell use: thermal management. High-temperature fuel cells allow increased performance, increased passenger carrying capability, and increased range compared to low-temperature fuel cell stack technology.

    US Army: Work continued at a good pace in the two new contracts with the U.S. Department of Defense ("DoD") ($2.2m and $2.8m awarded in 2023). Advent has successfully met all program milestones so far (on time or with minor delays) and the demanding mission requirements of the U.S. Army. These contracts are the continuation of a series of past contracts with the U.S. DoD, and their primary objective is to further optimize Advent's proprietary Honey Badger 50™ ("HB50") portable fuel cell system by integrating the Company's innovative Ion Pair MEA technology. Upon the completion of these contracts, Advent and the U.S. DoD aim to reinforce their long-term collaboration by focusing on the further optimization of the HB50 and also on low-volume production manufacturing capacity.

    Advent continued work for the ten EU-received R&D grants that are already ongoing and met milestones in multi-partner projects focused on further developing its technology and accelerating its product development roadmap.

    Advent continued work on developing the Advent MEA with the goal to eventually achieve three times (3x) the power density performance and the 3x the lifetime performance of the legacy MEA that has been used for the last years across the line of Serene products. Advent believes that the development of the MEA is essential to continue and precede mass market efforts. The experience with the Serene systems is that despite their design and system maturity they remain too expensive for the markets intended (especially telecom power backup in Asia and Africa). The expected introduction of the Advent MEA into new fuel cell systems codeveloped with OEMs can bring the cost three times down effectively creating an inflection point for mass adoption.

    Other Updates

    Reverse Stock Split: On May 1, 2024, Advent announced that it would move forward with a 1-for-30 reverse stock split of its issued and outstanding common stock. The reverse stock split was approved on April 30, 2024 by Advent's Board of Directors, following approval by the Company's stockholders at a special meeting held on April 29, 2024. The reverse stock split brought Advent back into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing and to make the Company's stock more attractive to a broader range of institutional and other investors. On May 9, 2024 Advent announced that it would file a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware after the close of business on Monday, May 13, 2024 to effectuate its previously announced 1-for-30 reverse stock split of its issued and outstanding common stock (the "Reverse Split").

    Dr. Gregoriou concluded, "We have continued our work on important projects with Airbus, US Army, Hyundai, and other automotive manufacturers. We are happy to report that despite financial difficulties, we have put our full focus and effort into these projects, and we have done our best work to date, meeting all the milestones. On the contrary, the Advent Denmark subsidiary has had poor financial and technology delivery performance, leading us to implement more cuts there. We intend to continue to reduce costs and focus our operations and people on what is truly world-changing and a competitive advantage for the company, and that is our Advent MEA technology. Furthermore, we are currently in talks with OEMs with the intention to enter into technology transfer agreements."

    About Advent Technologies Holdings, Inc.

    Advent Technologies Holdings, Inc. (a U.S. corporation) is an advanced materials and technology development company operating in the fuel cell, methanol, and hydrogen technology space. Advent is a world-leading company in the development of the HT-PEM technology (with more than 100 patents issued, pending, or licensed worldwide). The HT-PEM fuel cell technology developed by Advent enables off-grid power systems to produce clean power from various green fuels (hydrogen, methanol, bio and eMethanol, and renewable natural gas) and to function with higher efficiency at extreme ambient temperatures and in general extreme environmental conditions (humidity, air pollution). Advent's main operations focus on developing and manufacturing the Membrane Electrode Assembly (MEA), which is the core electrochemical element and the most critical component of the fuel cell. The MEA largely determines lifetime, power density, efficiency, and overall cost of installation and operation for all applications. Advent is working with world-leading market-leading OEMs with the goal of bringing to the market complete fuel cell systems for a range of applications in the stationary power markets (backup, off-grid, and portable power) and the heavy-duty mobility markets (automotive, aviation, marine).

    For more information, please visit www.advent.energy.

    Cautionary Note Regarding Forward-Looking Statements

    This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company's ability to maintain the listing of the Company's common stock on Nasdaq; future financial performance; public securities' potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees, and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance our corporate reputation and brand; expectations concerning our relationships and actions with our technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company's business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on August 13, 2024, as well as the other information we file with the SEC. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of these statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

    Presentation of Non-GAAP Financial Measures

    In addition to the results provided in accordance with U.S. GAAP throughout this press release, the Company has provided non-GAAP financial measures - Adjusted Net Income / (Loss) and Adjusted EBITDA - which present results on a basis adjusted for certain items. The Company uses these non-GAAP financial measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these non-GAAP financial measures are useful financial metrics to assess its operating performance from period-to- period by excluding certain items that the Company believes are not representative of its core business. These non- GAAP financial measures are not intended to replace, and should not be considered superior to, the presentation of the Company's financial results in accordance with GAAP. The use of the terms Adjusted Net Income / (Loss) and Adjusted EBITDA may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These measures are reconciled from the respective measures under GAAP in the appendix below.

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS



    (Amounts in USD thousands, except share and per share amounts)
     
      As of 
      June 30,

    2024
      December 31,

    2023
     
      (Unaudited)    
    ASSETS        
    Current assets:        
    Cash and cash equivalents $682  $3,562 
    Restricted cash, current  -   100 
    Accounts receivable, net  922   191 
    Contract assets  11   21 
    Inventories  1,986   2,707 
    Prepaid expenses and Other current assets  3,314   2,254 
    Total current assets  6,915   8,835 
    Non-current assets:        
    Intangibles, net  76   79 
    Property and equipment, net  6,734   21,549 
    Right-of-use assets  341   3,216 
    Restricted cash, non-current  -   750 
    Other non-current assets  303   308 
    Available for sale financial asset  -   - 
    Total non-current assets  7,454   25,902 
    Total assets $14,369  $34,737 
             
    LIABILITIES AND STOCKHOLDERS' EQUITY        
    Current liabilities:        
    Trade and other payables $6,283  $5,087 
    Deferred income from grants, current  7   530 
    Contract liabilities  2,221   2,015 
    Loss contingency liabilities  5,162   - 
    Other current liabilities  1,768   1,916 
    Operating lease liabilities  162   2,186 
    Income tax payable  176   179 
    Total current liabilities  15,779   11,913 
    Non-current liabilities:        
    Bonds and other long-term debt, net  537   - 
    Warrant liability  -   59 
    Long-term operating lease liabilities  170   8,230 
    Defined benefit obligation  91   83 
    Deferred income from grants, non-current  -   320 
    Other long-term liabilities  671   684 
    Total non-current liabilities  1,469   9,376 
    Total liabilities  17,248   21,289 
             
    Commitments and contingent liabilities        
             
    Stockholders' equity        
    Common stock ($0.0001 par value per share; Shares authorized: 500,000,000 at June 30, 2024 and December 31, 2023; Issued and outstanding: 2,636,508 and 2,580,159 at June 30, 2024 and December 31, 2023, respectively)  -   - 
    Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at June 30, 2024 and December 31, 2023; nil issued and outstanding at June 30, 2024 and December 31, 2023)  -   - 
    Additional paid-in capital  199,265   194,941 
    Accumulated other comprehensive loss  (2,356)  (2,334)
    Accumulated deficit  (199,788)  (179,159)
    Total stockholders' equity / (deficit)  (2,879)  13,448 
    Total liabilities and stockholders' equity $14,369  $34,737 



    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in USD thousands, except share and per share amounts)
     
      Three months ended

    June 30,

    (Unaudited)
      Six months ended

    June 30,

    (Unaudited)
     
      2024  2023  2024  2023 
    Revenue, net $805  $1,112  $4,256  $2,089 
    Cost of revenues  (155)  (1,905)  (1,174)  (3,389)
    Gross loss  650   (793)  3,082   (1,300)
    Income from grants  677   660   2,114   1,194 
    Research and development expenses  (3,587)  (2,883)  (5,002)  (6,024)
    Administrative and selling expenses  (6,372)  (8,331)  (13,275)  (16,820)
    Sublease income  -   138   145   265 
    Amortization of intangibles  (1)  (188)  (2)  (409)
    Credit loss – customer contracts  -   (127)  -   (127)
    Impairment losses  -   (9,763)  -   (9,763)
    Operating loss  (8,633)  (21,287)  (12,938)  (32,984)
    Fair value change of warrant liability  -   99   59   489 
    Finance income / (expenses), net  (54)  8   (286)  118 
    Foreign exchange gains / (losses), net  (156)  159   (165)  118 
    Loss contingency  36       (4,871)    
    Other income / (expenses), net  (2,466)  (806)  (2,483)  (760)
    Loss before income tax  (11,273)  (21,827)  (20,684)  (33,019)
    Income taxes  -   (4)  55   (800)
    Net loss $(11,273) $(21,831) $(20,629) $(33,819)
    Net loss per share                
    Basic loss per share  (4.28)  (12.26)  (7.91)  (19.25)
    Basic weighted average number of shares  2,634,179   1,780,574   2,609,549   1,757,137 
    Diluted loss per share  (4.28)  (12.26)  (7.91)  (19.25)
    Diluted weighted average number of shares  2,634,179   1,780,574   2,609,549   1,757,137 



    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



    (Amounts in USD thousands, except share and per share amounts)
     
      Six Months Ended

    June 30,

    (unaudited)
      
    (Amounts in thousands) 2024  2023  $ change  % change 
    Net Cash used in Operating Activities $(4,810) $(18,899) $14,089   (74.5)%
                     
    Cash Flows from Investing Activities:                
    Proceeds from sale of property and equipment  300   -   300   N/A 
    Purchases of property and equipment  (28)  (2,348)  2,320   (98.8)%
    Advances for the acquisition of property and equipment  -   (1,214)  1,214   N/A 
    Acquisition of subsidiaries  -   (1,864)  1,864   N/A 
    Net Cash provided by / (used in) Investing Activities $272  $(5,426) $5,698   (105.0)%
                     
    Cash Flows from Financing Activities:                
    Proceeds from issuance of common stock and paid-in capital  282   3,410   (3,128)  (91.7)%
    Proceeds from borrowings  540   -   540   N/A 
    Net cash provided by Financing Activities $822  $3,410  $(2,588)  (75.9)%
                     
    Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents $(3,716) $(20,915) $17,199   (82.2)%
    Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents  (14)  94   (108)  (114.9)%
    Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of year  4,412   33,619   (29,207)  (86.9)%
    Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of period $682  $12,798  $(12,116)  (94.7)%



    Supplemental Non-GAAP Measures and Reconciliations

    In addition to providing measures prepared in accordance with GAAP, we present certain supplemental non-GAAP measures. These measures are EBITDA, Adjusted EBITDA and Adjusted Net Income / (Loss), which we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our peers. These non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore may differ from similar measures presented by other companies and may not be comparable to other similarly titled measures. We believe these measures are useful in evaluating the operating performance of Advent's ongoing business. These measures should be considered in addition to, and not as a substitute for net income, operating expense and income, cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. The calculation of these non-GAAP measures has been made on a consistent basis for all periods presented.

    EBITDA and Adjusted EBITDA

    These supplemental non-GAAP measures are provided to assist readers in determining our operating performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. We also believe EBITDA and Adjusted EBITDA are frequently used by securities analysts and investors when comparing our results with those of other companies. EBITDA differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include interest, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for items such as one-time transaction costs, asset impairment charges, and fair value changes in the warrant liability.

    The following tables show a reconciliation of net loss to EBITDA and Adjusted EBITDA for the three and six months ended June 30, 2024 and 2023.

    EBITDA and Adjusted EBITDA Three months ended

    June 30,

    (Unaudited)
         Six months ended

    June 30,

    (Unaudited)
        
    (in Millions of US dollars) 2024  2023  $ change  2024  2023  $ change 
    Net loss $(11.27) $(21.83)  10.56  $(20.63) $(33.82)  13.19 
    Depreciation of property and equipment $0.40  $0.81   (0.41) $1.12  $1.21   (0.09)
    Amortization of intangibles $-  $0.19   (0.19) $-  $0.41   (0.41)
    Finance income / (expenses), net $0.06  $(0.01)  0.07  $0.29  $(0.12)  0.41 
    Loss contingency $(0.04) $-   (0.04) $4.87  $-   4.87 
    Other income / (expenses), net $2.46  $0.81   1.65  $2.48  $0.76   1.72 
    Foreign exchange differences, net $0.16  $(0.16)  0.32  $0.17  $(0.12)  0.29 
    Income taxes $-  $-   -  $(0.06) $0.80   (0.86)
    EBITDA $(8.23) $(20.19)  11.96  $(11.76) $(30.88)  19.12 
    Net change in warrant liability $-  $(0.10)  0.10  $(0.06) $(0.49)  0.43 
    Impairment losses $-  $9.76   (9.76) $-  $9.76   (9.76)
    Adjusted EBITDA $(8.23) $(10.53)  2.30  $(11.82) $(21.61)  9.79 



    This supplemental non-GAAP measure is provided to assist readers in determining our financial performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. Adjusted Net Loss differs from the most comparable GAAP measure, net loss, primarily because it does not include one-time transaction costs, asset impairment charges and warrant liability changes. The following table shows a reconciliation of net loss to Adjusted Net Loss for the three and six months ended June 30, 2024 and 2023.

    Adjusted Net Loss Three months ended

    June 30,

    (Unaudited)
         Six months ended

    June 30,

    (Unaudited)
        
    (in Millions of US dollars) 2024  2023  $ change  2024  2023  $ change 
    Net loss $(11.27) $(21.83)  10.56  $(20.63) $(33.82)  13.19 
    Net change in warrant liability $-  $(0.10)  0.10  $(0.06) $(0.49)  0.43 
    Impairment losses $-  $9.76   (9.76) $-  $9.76   (9.76)
    Adjusted Net Loss $(11.27) $(12.17)  0.90  $(20.69) $(24.55)  3.86 

    Advent Technologies Holdings, Inc.

    Dr. Vasilis Gregoriou,

    [email protected]

    Source: Advent Technologies Holdings, Inc.



    Primary Logo

    Get the next $ADN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Advent Technologies downgraded by Goldman with a new price target

    Goldman downgraded Advent Technologies from Buy to Neutral and set a new price target of $20.00

    5/18/21 6:31:17 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Jefferies initiated coverage on Advent Technologies with a new price target

    Jefferies initiated coverage of Advent Technologies with a rating of Buy and set a new price target of $18.00

    3/19/21 8:01:58 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Credit Suisse reiterated coverage on Acadian Timber with a new price target

    Credit Suisse reiterated coverage of Acadian Timber with a rating of Underperform and set a new price target of $18.00 from $16.00 previously

    3/17/21 8:43:34 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    SEC Filings

    View All

    SEC Form 25-NSE filed by Advent Technologies Holdings Inc.

    25-NSE - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    1/21/26 3:05:57 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 25-NSE filed by Advent Technologies Holdings Inc.

    25-NSE - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    1/21/26 3:02:10 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

    1/14/26 5:39:52 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Advent Technologies Powers the Future of Flight with Next-Generation Fuel Cell Technology

    LIVERMORE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in fuel cell and hydrogen technology, is accelerating the electrification of aviation through its cutting-edge high-temperature proton exchange membrane fuel cells (HT-PEM FCs). In collaboration with Stralis Aircraft and other aerospace pioneers, Advent's technology is helping enable the next generation of sustainable flight — from fixed-wing aircraft and eVTOL taxis to emerging flying car platforms. "More than 100 companies — from startups to established aerospace leaders — are developing electric flight solutions," said Gary Herman, Chief Executive Officer of

    10/29/25 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Commissions Arxicon as Master Planner for RHyno Project

    LIVERMORE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project management firm, for the development of its master plan for the RHyno Project. The RHyno Project officially commenced on April 1, 2025, and is funded by the EU Innovation Fund. It involves the development and construction of the facility and key infrastructure for manufacturing innovative fuel cells, electrolysers, and their critical components, including Advent's cutting-edge Membrane Electrode Assembly (MEA) technology, at

    10/27/25 8:45:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent to Present at the International Energy Agency Conference on Fuel Cell Applications in the Maritime Sector

    LIVERMORE, Calif. , Oct. 09, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), is pleased to announce that Dr. Emory De Castro, the Company's Chief Technology Officer, will speak at the International Energy Agency (IEA) conference to be held in Paris, France on November 6, 2025. Advent's presentation is "Next Generation Components for HT-PEM and Their Relevance in Marine Applications," whereby the Ion Pair™ membrane electrode assembly (MEA) will be featured. This breakthrough MEA technology greatly increases the lifetime and reduces the space requirements of high temperature proton exchange membrane (HT-PEM) fuel cells for on-board ship applications. Dr. De Castro

    10/9/25 11:45:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Dhaliwal Avtar

    4 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    4/2/25 2:16:33 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Dhaliwal Avtar

    3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    4/2/25 2:15:48 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Lukash Seth M

    3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    3/11/25 5:56:13 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Financials

    Live finance-specific insights

    View All

    Advent Technologies Reports Q4 2023 Results

    Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, announced on Tuesday, August 13, 2024 its consolidated financial results for the three months and year ended December 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Q4 2023 Financial Highlights (All comparisons are to Q4 2022, unless otherwise stated) Revenue of $1.5 million and income from grants of $0.8 million, totaling $2.3 million, which represents a decrease of (3.6)% year-over-year. Full year 2023 revenue of $

    8/20/24 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Announces Date for Fourth Quarter and Fiscal 2023 Earnings Call

    Company to Report Q4 2023 Results on August 20, 2024 Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it will host a conference call on Tuesday, August 20, 2024 at 9:00 AM ET to discuss its fourth quarter and fiscal 2023 financial results. A press release containing these results will be issued before the call. To access the call please dial (800) 715-9871 from the United States, or +1 (646) 307-1963 from outside the U.S. The conference call I.D. number is 9909908. Participants should dial in 5 to 10 minutes before the scheduled time. Participants can also attend the call virtually by vi

    8/14/24 9:28:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Reports Q3 2023 Results

    Operational Highlights Signed a term sheet with Airbus to launch a Joint Project for the potential use of HT-PEM fuel cells in aviation. Signed new supply contract with the U.S. Department of Defense of $2.2 million for portable power systems. Received order from a prominent fuel cell integrator in the Asian market with initial value of $1.3 million. Unveiled Advent's range of Serene Power Systems at the 2023 Monaco Yacht Show. Continued discussions with the Greek State to finalize its procedures for state aid funding of Advent's Green HiPo project, following official ratification from the European Commission under the Important Projects of Common European Interest ("IPCEI")

    11/14/23 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Leadership Updates

    Live Leadership Updates

    View All

    Advent Technologies Commissions Arxicon as Master Planner for RHyno Project

    LIVERMORE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project management firm, for the development of its master plan for the RHyno Project. The RHyno Project officially commenced on April 1, 2025, and is funded by the EU Innovation Fund. It involves the development and construction of the facility and key infrastructure for manufacturing innovative fuel cells, electrolysers, and their critical components, including Advent's cutting-edge Membrane Electrode Assembly (MEA) technology, at

    10/27/25 8:45:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Announces Management and Board Changes

    LIVERMORE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce changes to its board and C-suite by removing Chairman and Chief Executive Officer, Vasilis Gregoriou and Chief Strategy Officer, Chris Kaskavelis. Gary Herman, an experienced turnaround executive has been appointed as Interim CEO. Mr. Herman stated, "The changes were long overdue. Advent has tremendous untapped potential. Its technology is unsurpassed and offers a ubiquitous clean energy solution across multiple industries including aviation, heavy automotive,

    10/30/24 6:10:38 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Receives Nasdaq Notification Regarding Compliance with Listing Requirements and Appoints Three New Directors

    Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") confirming that the Company has rectified its previous deficiency related to the filing of its annual report on Form 10-K on August 13, 2024. The letter also informed Advent Technologies that it remains noncompliant with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 (the "First Quarter 10-Q") and June 30, 2024 (the "Second Quarter 10-Q" and, together with t

    9/4/24 6:01:00 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    2/12/24 4:09:47 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    1/10/24 2:49:54 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    10/3/23 9:43:40 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous